Mind-Body-Medizin bei Patienten mit Prostatakarzinom

Summary

Die Mind-Body-Medizin zielt darauf ab, Patienten Kompetenzen zu vermitteln, wie sie mithilfe einer Lebensstilmodifikation zu ihrer Genesung oder Gesunderhaltung beitragen können. Methoden der Mind-Body-Medizin umfassen unter anderem Entspannungstechniken wie Meditation oder Yoga, Bewegung, gesunde Ernährung oder Resilienztrainings. Studien belegen, dass Programme der Mind-Body-Medizin die Lebensqualität von Patienten mit Prostatakrebs erhöhen, psychische sowie körperliche Symptome lindern und sogar langfristig einen positiven Effekt auf die Genexpression und damit den Krankheitsverlauf haben können.

Keywords

Krebs - Uroonkologie - Prostatakarzinom - Mind-Body-Medizin - Naturheilkunde

Publikationsverlauf

Artikel online veröffentlicht:
16. Mai 2024

• Literatur

• 1 Bishop FL, Rea A, Lewith H. et al Complementary medicine use by men with prostate cancer: A systematic review of prevalence studies. Prostate Cancer Prostatic Dis 2011; 14: 1-13
• 2 Bower JE, Irwin MR. Mind-body therapies and control of inflammatory biology: A descriptive review. Brain Behav Immun 2016; 51: 1-11
• 3 Cramer H, Lauche R, Langhorst J. et al Is one yoga style better than another? A systematic review of associations of yoga style and conclusions in randomized yoga trials. Complement Ther Med 2016; 25: 178-187
• 4 Cramer H, Lauche R, Hohmann C. et al Yoga for chronic neck pain: A 12-month follow-up. Pain Med 2013; 14 (04) 541-548
• 5 Daubenmier JJ, Weidner G, Ornish D. et al Lifestyle and health-related quality of life of men with prostate cancer managed with active surveillance. Urology 2006; 67 (01) 125-130
• 6 Dobos G, Overhamm T, Bussing A. et al Integrating mindfulness in supportive cancer care: A cohort study on a mindfulness-based day care clinic for cancer survivors. Support Care Cancer 2015; 23 (10) 2945-2955
• 7 Farber F, Rosendahl J. The association between resilience and mental health in the somatically ill. Dtsch Arztebl Int 2018; 115 (38) 621-627
• 8 Frattaroli J, Weidner G, Dnistrian AM. et al Clinical events in prostate cancer lifestyle trial: Results from two years of follow-up. Urology 2008; 72 (06) 1319-1323
• 9 Groarke A, Curtis R, Skelton J. et al Quality of life and adjustment in men with prostate cancer: Interplay of stress, threat and resilience. PLoS One 2020; 15 (09) e0239469
• 10 Hilfiker R, Meichtry A, Eicher M. et al Exercise and other non-pharmaceutical interventions for cancer-related fatigue in patients during or after cancer treatment: A systematic review incorporating an indirect-comparisons meta-analysis. Br J Sports Med 2018; 52 (10) 651-658
• 11 Kiecolt-Glaser JK, Bennett JM. et al Yoga's impact on inflammation, mood, and fatigue in breast cancer survivors: A randomized controlled trial. J Clin Oncol 2014; 32 (10) 1040-1049
• 12 Ludolph P, Kunzler AM, Stoffers-Winterling J. et al Interventions to promote resilience in cancer patients. Dtsch Arztebl Int 2019; 116: 865-872
• 13 Lutgendorf SK, De Geest K, Bender D. et al Social influences on clinical outcomes of patients with ovarian cancer. J Clin Oncol 2012; 30 (23) 2885-2890
• 14 Ornish D, Magbanua MJ, Weidner G. et al Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci 2008; 105 (24) 8369-8374
• 15 Ornish D, Lin J, Chan JM. et al Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol 2013; 14 (11) 1112-1120
• 16 Paul A, Lange S, Voiß P.. Integrative Onkologie an den Kliniken Essen-Mitte. In: Dobos G, Paul A, Hrsg. Mind-Body-Medizin. 2. Aufl. München: Elsevier; 2019: 225-235
• 17 Scandurra C, Mangiapia F, La Rocca R. et al A cross-sectional study on demoralization in prostate cancer patients: The role of masculine self-esteem, depression, and resilience. Support Care Cancer 2022; 30 (08) 7021-7030
• 18 Tawakol A, Ishai A, Takx RA. et al Relation between resting amygdalar activity and cardiovascular events: A longitudinal and cohort study. Lancet 2017; 389 10071 834-845